Cellectis S.A.CLLSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank90
5Y CAGR+73.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+73.2%/yr
Long-term compound
Percentile
P90
Near historical high
vs 5Y Ago
15.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 102.46% |
| Q2 2025 | -33.33% |
| Q1 2025 | -404.05% |
| Q4 2024 | 125.74% |
| Q3 2024 | 17.86% |
| Q2 2024 | -456.23% |
| Q1 2024 | 113.10% |
| Q4 2023 | -93.55% |
| Q3 2023 | -63.16% |
| Q2 2023 | 67.24% |
| Q1 2023 | -3.57% |
| Q4 2022 | -1.82% |
| Q3 2022 | -30.95% |
| Q2 2022 | 40.00% |
| Q1 2022 | 21.35% |
| Q4 2021 | -8.54% |
| Q3 2021 | 6.82% |
| Q2 2021 | -214.29% |
| Q1 2021 | 70.83% |
| Q4 2020 | -35.21% |
| Q3 2020 | 6.58% |
| Q2 2020 | -261.70% |
| Q1 2020 | 152.81% |
| Q4 2019 | -134.21% |
| Q3 2019 | 51.90% |
| Q2 2019 | -119.44% |
| Q1 2019 | 33.33% |
| Q4 2018 | 0.00% |
| Q3 2018 | -217.65% |
| Q2 2018 | 76.06% |
| Q1 2018 | 6.58% |
| Q4 2017 | -4.11% |
| Q3 2017 | 6.41% |
| Q2 2017 | -39.29% |
| Q1 2017 | -51.35% |
| Q4 2016 | 7.50% |
| Q3 2016 | -100.00% |
| Q2 2016 | 78.95% |
| Q1 2016 | -480.00% |
| Q4 2015 | 160.98% |